Francisco José
Maceiras Pan
Publicacións (28) Publicacións de Francisco José Maceiras Pan
2025
-
Cerebrovascular accidents in giant cell arteritis: prevalence and predictive factors from the ARTESER registry
Rheumatology, Vol. 64, Núm. 6, pp. 3733-3738
-
Epidemiology of major and minor relapses in giant cell arteritis according to EULAR definitions: Insights from the ARTESER registry
Rheumatology, Vol. 64, Núm. 9, pp. 4985-4994
-
Mortality in patients with giant cell arteritis in Spain: results from the ARTESER registry
Arthritis Research and Therapy, Vol. 27, Núm. 1
-
Visual manifestations in giant cell arteritis: Identification of risk factors from the ARTESER Registry
Rheumatology, Vol. 64, Núm. 2, pp. 697-703
2024
-
Real-world apremilast use in biologic-naïve psoriatic arthritis patients. Data from Spanish clinical practice
Reumatologia Clinica, Vol. 20, Núm. 1, pp. 24-31
-
Semaphorin3B promotes an anti-inflammatory and pro-resolving phenotype in macrophages from rheumatoid arthritis patients in a MerTK-dependent manner
Frontiers in Immunology, Vol. 14
-
The activity of psoriatic arthritis with axial involvement correlates with the PsAID12
Reumatologia Clinica, Vol. 20, Núm. 2, pp. 80-83
2022
-
Analysis of the implementation of an innovative IT solution to improve waiting times, communication with primary care and efficiency in Rheumatology
BMC Health Services Research, Vol. 22, Núm. 1
2021
-
Direct costs in patients with chronic inflammatory arthropathies on biological therapy: A real-world data study
Clinical and Experimental Rheumatology, Vol. 39, Núm. 4, pp. 736-745
-
Epidemiological Characteristics and Adverse Events of Patients with Psoriatic Arthritis Undergoing Treatment with Biological Therapies in Galicia
Reumatologia Clinica, Vol. 17, Núm. 3, pp. 150-154
-
Medication persistence on biological therapies prescribed for the treatment of chronic inflammatory arthropathies: a real-world data study
European Journal of Hospital Pharmacy, Vol. 28, Núm. e1, pp. E47-E50
-
Secukinumab as Biological Treatment for Psoriatic Arthritis in Real Clinical Practice
Reumatologia Clinica, Vol. 17, Núm. 4, pp. 203-206
2020
-
Current status of multidisciplinary care in psoriatic arthritis in Spain: NEXUS 2.0 project
Reumatologia Clinica, Vol. 16, Núm. 1, pp. 24-31
-
Efficacy and Safety of Combined Therapy With Synthetic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis: Systematic Literature Review
Reumatologia Clinica, Vol. 16, Núm. 5P1, pp. 324-332
-
Satisfaction, fulfillment of expectations and adherence to subcutaneous biological drugs in patients with rheumatoid arthritis: ARCO study
Reumatologia Clinica, Vol. 16, Núm. 2P1, pp. 116-119
2019
-
Adherence to biological therapies in patients with chronic inflammatory arthropathies
Farmacia Hospitalaria, Vol. 43, Núm. 4, pp. 134-139
-
Correlation of fatigue with other disease related and psychosocial factors in patients with rheumatoid arthritis treated with tocilizumab
Medicine, Vol. 98, Núm. 26, pp. e15947
-
Spanish Registry of Recent-onset Psoriatic Arthritis (REAPSER study): Aims and methodology
Reumatologia Clinica, Vol. 15, Núm. 5, pp. 252-257
2017
-
Non-adherence to subcutaneous biological medication in patients with rheumatoid arthritis: A multicentre, non-interventional study
Clinical and Experimental Rheumatology, Vol. 35, Núm. 3, pp. 423-430
2006
-
Desarrollo y validación de un cuestionario de satisfacción con el tratamiento en pacientes con artritis reumatoide
Reumatologia Clinica, Vol. 2, Núm. 3, pp. 137-145